Brimonidine/timolol
Brimonidine/Timolol is a combination ophthalmic medication used for the treatment of glaucoma and ocular hypertension. It consists of two active ingredients:
- Brimonidine: An alpha-2 adrenergic receptor agonist that reduces aqueous humor production and increases uveoscleral outflow.
- Timolol: A non-selective beta-blocker that decreases intraocular pressure (IOP) by reducing aqueous humor production.
This combination is prescribed for patients who require additional intraocular pressure (IOP) reduction beyond monotherapy.
Mechanism of Action[edit]
The combination of brimonidine and timolol works synergistically to lower intraocular pressure:
Brimonidine (Alpha-2 Agonist)[edit]
- Reduces the production of aqueous humor in the ciliary body.
- Increases uveoscleral outflow, facilitating the drainage of aqueous humor.
- Reduces IOP without significant cardiovascular effects.
Timolol (Beta-Blocker)[edit]
- Blocks beta-adrenergic receptors in the ciliary epithelium.
- Decreases aqueous humor production, lowering intraocular pressure.
- Has no significant effect on aqueous humor outflow.
The dual mechanism provides a greater IOP-lowering effect compared to either drug alone.
Indications[edit]
Brimonidine/Timolol is primarily indicated for:
- Glaucoma: Specifically primary open-angle glaucoma, where elevated intraocular pressure can damage the optic nerve.
- Ocular hypertension: Increased intraocular pressure without optic nerve damage or visual field loss.
Dosage and Administration[edit]
- The typical dosage is one drop in the affected eye(s) twice daily.
- It is administered topically as an ophthalmic solution.
- Patients should wait at least 5 minutes before using other eye medications.
- Contact lenses should be removed before application and reinserted 15 minutes after administration.
Contraindications[edit]
Brimonidine/Timolol should not be used in patients with:
- Hypersensitivity to brimonidine, timolol, or excipients in the formulation.
- Bronchial asthma or severe chronic obstructive pulmonary disease (COPD).
- Sinus bradycardia or second- or third-degree atrioventricular (AV) block.
- Cardiogenic shock or overt heart failure.
Side Effects[edit]
Like all medications, Brimonidine/Timolol may cause side effects, including:
Common Side Effects[edit]
- Ocular effects:
- Eye irritation or redness
- Dry eyes
- Blurred vision
- Burning or stinging sensation
- Systemic effects:
- Fatigue and drowsiness
- Dizziness
- Headache
- Dry mouth
Serious Adverse Reactions[edit]
- Bradycardia (slow heart rate)
- Hypotension
- Bronchospasm in patients with respiratory disorders
- Depression and mood changes
- Severe allergic reactions (rare)
Patients experiencing significant side effects should seek medical attention.
Drug Interactions[edit]
Brimonidine/Timolol may interact with various medications:
- Beta-blockers (oral or topical) – May cause additive cardiovascular effects.
- Antihypertensive drugs – Can enhance hypotensive effects.
- CNS depressants (sedatives, alcohol, opioids) – Increased drowsiness.
- Monoamine oxidase inhibitors (MAOIs) – Risk of severe hypotension with brimonidine.
Patients should inform their healthcare provider about all medications they are taking.
Special Precautions[edit]
Pregnancy and Breastfeeding[edit]
- Pregnancy – Use only if the potential benefit outweighs the risk.
- Breastfeeding – Timolol is excreted in breast milk; caution is advised.
Use in Pediatric and Geriatric Populations[edit]
- Pediatrics: Not recommended for children under 2 years old due to the risk of central nervous system depression.
- Geriatrics: Increased risk of systemic beta-blockade effects.
Storage and Handling[edit]
- Store at room temperature (15-25°C).
- Keep the bottle tightly closed to prevent contamination.
- Avoid touching the dropper tip to any surface.
- Discard after the expiration date.
See Also[edit]
External Links[edit]
| Routes of administration, dosage forms | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Beta blockers (C07) | ||||||||
|---|---|---|---|---|---|---|---|---|
|
| Pharmacology | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Drugs used for glaucoma preparations and miosis (S01E) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


